Novartis AG
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2016 | $2.80 | $3.66 |
| FY2017 | $3.25 | $3.91 |
| FY2018 | $5.38 | $4.85 |
| FY2019 | $5.06 | $5.19 |
| FY2020 | $3.52 | $5.00 |
| FY2021 | $10.63 | $6.22 |
| FY2022 | $3.17 | $5.82 |
| FY2023 | $7.10 | $6.00 |
| FY2024 | $5.87 | $5.99 |
| FY2025 | $7.15 | $6.10 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2016 | $2.80 | $3.66 |
| FY2017 | $3.25 | $3.91 |
| FY2018 | $5.38 | $4.85 |
| FY2019 | $5.06 | $5.19 |
| FY2020 | $3.52 | $5.00 |
| FY2021 | $10.63 | $6.22 |
| FY2022 | $3.17 | $5.82 |
| FY2023 | $7.10 | $6.00 |
| FY2024 | $5.87 | $5.99 |
| FY2025 | $7.15 | $6.10 |